Content about Boots UK

May 17, 2013
U.K. deal-maker Stefano Pessina confident in profitable 2013-2014 for Alliance Boots

Alliance Boots posted a double-digit adjusted profit gain of 12.7% to $1.2 billion for its year ended March 31. Almost half of that profit is staked by Walgreens with its 45% share of the European pharmaceutical distributing powerhouse.

A couple days later, Alliance Boots along with Walgreens and AmerisourceBergen announced the necessary regulatory clearances on that strategic partnership, cementing the three companies in place as the largest generic pharmaceutical acquisition company in the world. That deal will further enable the company's to realize greater profit margins.

Alliance Boots posted a double-digit adjusted profit gain of 12.7% to $1.2 billion for its year ended March 31. Almost half of that profit is staked by Walgreens with its 45% share of the European pharmaceutical distributing powerhouse. 

May 17, 2013
Walgreens and Alliance Boots strategic partnership with AmerisourceBergen clears any regulatory hurdle

The deal that paired Walgreens and Alliance Boots with wholesaler AmerisourceBergen has received the required regulatory clearances, the companies announced Friday.

DEERFIELD, Ill. — The deal that paired Walgreens and Alliance Boots with wholesaler AmerisourceBergen has received the required regulatory clearances, the companies announced Friday. 

The regulatory clearances permit both Walgreens and Alliance Boots the purchase of up to 7% of the fully diluted equity of AmerisourceBergen in the open market, and the exercise of two warrants for 16% in the aggregate of the fully diluted equity of AmerisourceBergen in 2016 and 2017. 

May 15, 2013
Double-digit profit gains for Alliance Boots

Alliance Boots on Wednesday reported a double-digit profit gain for its year ended March 31.

BERN, Switzerland — Alliance Boots on Wednesday reported a double-digit profit gain for its year ended March 31. Underlying profit after tax was up 12.7% to $1.2 billion, though revenue was down slightly by 2.6% to $34.2 billion. 

May 10, 2013
Alliance Boots distributes equity interest in Galenica

Alliance Boots on Friday announced that it has distributed its equity interest in Galenica, its Swiss associate, to the group’s ultimate parent company, AB Acquisitions Holdings, in accordance with the terms of the agreement with Walgreens reached last year.

BERN, Switzerland — Alliance Boots on Friday announced that it has distributed its equity interest in Galenica, its Swiss associate, to the group’s ultimate parent company, AB Acquisitions Holdings, in accordance with the terms of the agreement with Walgreens reached last year.

Galenica continues as an associate of AB Acquisitions Holdings. Stefano Pessina, executive chairman of Alliance Boots, continues as non-executive director of Galenica while Etienne Jornod, executive chairman of Galenica, stays as a non-executive director of Alliance Boots.

April 22, 2013
WAG's latest moves offer brighter outlook on Wall Street

To the skepticism of many, Walgreens last year made a big global splash with its two-step merger deal with Alliance Boots across the pond. But with the announcement that the co-joined Walgreens/Alliance Boots had signed a 10-year distribution deal with wholesaler AmerisourceBergen, that included an equity stake to boot, well, it seemed that many analysts on Wall Street finally got it.

To the skepticism of many, Walgreens last year made a big global splash with its two-step merger deal with Alliance Boots across the pond. But with the announcement that the co-joined Walgreens/Alliance Boots had signed a 10-year distribution deal with wholesaler AmerisourceBergen, that included an equity stake to boot, well, it seemed that many analysts on Wall Street finally got it.

March 27, 2013
Alliance Boots to refocus contract manufacturing business on beauty, skin care product development

Alliance Boots on Wednesday announced its contract manufacturing business BCM will invest heavier into core competency categories, such as beauty and skin care, as it discontinues third-party manufacturer development in unnamed "unprofitable" categories.

LONDON — Alliance Boots on Wednesday announced its contract manufacturing business BCM will invest heavier into core competency categories, such as beauty and skin care, as it discontinues third-party manufacturer development in unnamed "unprofitable" categories. 

March 22, 2013
Walgreens, Alliance Boots and AmerisourceBergen help redefine economies of scale

Walgreens and Alliance Boots entered into a 10-year contract with wholesaler AmerisourceBergen on sourcing pharmaceuticals last week. But that's not all. Besides the long-term contract, Walgreens and Alliance Boots will have the option on a potential 23% equity stake in ABC in three years.

The deal takes pharmaceutical buying leverage to the stratosphere and changes the face of more than one health service industry. As Adam Fein, president of Pembroke Consulting, noted in a live television interview on Fox Business' "Money With Melissa Francis": "Three of the largest companies in the pharmaceutical industry have come together and built the single largest buyer of prescription drugs in the world," he said.

Walgreens and Alliance Boots entered into a 10-year contract with wholesaler AmerisourceBergen on sourcing pharmaceuticals last week. But that's not all. Besides the long-term contract, Walgreens and Alliance Boots will have the option on a potential 23% equity stake in ABC in three years. 

March 19, 2013
Walgreens, Alliance Boots announce blockbuster partnership with AmerisourceBergen

Walgreens will no longer source branded prescription medicines directly from suppliers beginning in September, the Chicago-based retailer announced as part of a significant partnership between Walgreens, Alliance Boots and AmerisourceBergen that includes Walgreens and Alliance Boots potentially taking a 7% stake in the Pennsylvania wholesaler.

DEERFIELD, Ill. — Walgreens will no longer source branded prescription medicines directly from suppliers beginning in September, the Chicago-based retailer announced Tuesday as part of a significant partnership between Walgreens, Alliance Boots and AmerisourceBergen that includes Walgreens and Alliance Boots potentially taking a 7% stake in the Pennsylvania wholesaler. Walgreens will begin sourcing generic medicines from AmerisourceBergen beginning in the calendar year 2014.  

February 13, 2013
Walgreens, Alliance Boots provide analysts color on global pharmacy opportunity

Walgreens and Alliance Boots will generate $130 billion or more in combined sales, Greg Wasson, Walgreens president and CEO told analysts Wednesday.

LONDON — Walgreens and Alliance Boots will generate $130 billion or more in combined sales, Greg Wasson, Walgreens president and CEO, told analysts Wednesday. Walgreens and Alliance Boots offered analysts a firsthand look at the Alliance Boots operation here, beginning with a store tour and then leading into presentations. 

November 29, 2012
Merger of WAG, Alliance Boots creates global Rx, HBA giant

It’s a marriage of industry icons. In June, Walgreens finally made a long-awaited leap across the Atlantic to acquire British-based Alliance Boots, one of the world’s premier retailers of pharmaceuticals, health and beauty aids, and beauty care products. 


It’s a marriage of industry icons. In June, Walgreens finally made a long-awaited leap across the Atlantic to acquire British-based Alliance Boots, one of the world’s premier retailers of pharmaceuticals, health and beauty aids, and beauty care products. 


November 7, 2012
Boots U.K. testing in-store health guides armed with tablets

Boots U.K. recently took a page out of Walgreens' playbook with the placement of health guides across the front-end.

LONDON — Boots U.K. recently took a page out of Walgreens' playbook with the placement of health guides across the front-end. 

As part of its multi-channel strategy, Boots U.K. is currently testing the use of iPads to support in-store ordering across 30 stores, the London-based drug store retailer recently announced. 

November 2, 2012
Alliance Boots takes ownership of Alliance Healthcare Russia

Alliance Boots on Thursday announced that it has acquired ownership of its associate, Alliance Healthcare Russia, from AB Acquisitions Holdings Limited, the ultimate parent company of Alliance Boots.

ZUG, Switzerland — Alliance Boots on Thursday announced that it has acquired ownership of its associate, Alliance Healthcare Russia, from AB Acquisitions Holdings Limited, the ultimate parent company of Alliance Boots.

This follows the recently established strategic partnership with Walgreens, which included, among other things, an option for Walgreens to acquire the Alliance Healthcare Russia shareholding on exercise of its option to proceed to a full merger with Alliance Boots.

 

 

November 2, 2012
Walgreens setting the stage to be an entirely different retailer; new magazine just a first step in that direction

Omni-channel retailing is so yesterday. Omni-national retailing is the space where Walgreens is looking to play, and this magazine is just one of the first examples of how retailing concepts from the Old Country will be imported from across the Pond and translated for the U.S. market.

(THE NEWS: Walgreens launches new biannual magazine showcasing private label, Balance Rewards deals. For the full story, click here.)

WHAT IT MEANS AND WHY IT'S IMPORTANT — Omni-channel retailing is so yesterday. Omni-national retailing is the space where Walgreens is looking to play, and this magazine is just one of the first examples of how retailing concepts from the Old Country will be imported from across the Pond and translated for the U.S. market. 

October 31, 2012
Walgreens, Alliance Boots form new jointly owned company: Walgreens Boots Alliance Development

Walgreens on Tuesday announced that it has formally set up a new company, jointly owned with Alliance Boots, as part of their strategic partnership’s synergy program.

DEERFIELD, Ill. — Walgreens on Tuesday announced that it has formally set up a new company, jointly owned with Alliance Boots, as part of their strategic partnership’s synergy program.

The new company, called Walgreens Boots Alliance Development, will be based in Bern, Switzerland.

No other details were released. 

September 25, 2012
Breaking down the 
WAG-Alliance Boots deal

In June, Walgreens announced a two-step investment in a strategic partnership with Alliance Boots, to acquire a 45% equity stake in the privately held company for $6.7 billion in cash and stock in the first step with the option to acquire the other 55% approximately three years down the road at what is today being projected to be another $9.5 billion price tag in cash and stock. 


In June, Walgreens announced a two-step investment in a strategic partnership with Alliance Boots, to acquire a 45% equity stake in the privately held company for $6.7 billion in cash and stock in the first step with the option to acquire the other 55% approximately three years down the road at what is today being projected to be another $9.5 billion price tag in cash and stock. 


September 25, 2012
Why Alliance Boots?

As the largest single purchaser of prescription drugs in the world, with a global pharmaceutical wholesale operation to match, in-house manufacturing capabilities in over-the-counter health and wellness and generic drugs, Walgreens-Alliance Boots will have a whole lot more influence on the pharmacy side of its business.


Much has been written already about Walgreens’ epic, two-step acquisition of Alliance Boots that in the end could be valued at $16 billion. As the largest single purchaser of prescription drugs in the world, with a global pharmaceutical wholesale operation to match, in-house manufacturing capabilities in over-the-counter health and wellness and generic drugs, Walgreens-Alliance Boots will have a whole lot more influence on the pharmacy side of its business.


September 20, 2012
Alliance Boots acquires stake in Chinese wholesale market

Alliance Boots, under the terms of a strategic alliance agreement signed earlier this week, announced that it will acquire a 12% stake in Nanjing Pharmaceutical for a total consideration of approximately $90.7 million.

LONDON — Alliance Boots, under the terms of a strategic alliance agreement signed earlier this week, announced that it will acquire a 12% stake in Nanjing Pharmaceutical for a total consideration of approximately $90.7 million. On completion of the transaction, which is subject to various regulatory approvals, Alliance Boots will be the second largest shareholder in Nanjing Pharmaceutical with board and operational management representation.